Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day".

This resolution (HRES 394) expresses congressional support for designating July 16, 2025, as "Glioblastoma Awareness Day." It aims to raise public awareness about glioblastoma, a highly aggressive and deadly brain cancer with a 6.9% 5-year survival rate. The resolution encourages greater attention to the disease's urgent unmet medical needs and supports research efforts, including the Glioblastoma Therapeutics Network. It directly affects patients, caregivers, and researchers by promoting recognition of the disease and urging collaborative efforts to improve treatments.